Press Releases

Cancer vaccine company DCPrime BV today announced that it has entered into a research and optional license agreement with Janssen Pharmaceuticals Inc. The collaboration has been facilitated in conjunction with the Johnson & Johnson London Innovation Centre where a...

Marshall Gerstein & Borun LLP an intellectual property law firm was recognized as Patent Strategy and Management: Team of the Year by LMG Life Sciences during the LMG Life Sciences Awards ceremony held on September 25 2013 at the...

Approval to manufacture highly potent compound for breakthrough pain relief in cancer treatment granted. 23 September 2013, Recipharm Stockholm  is pleased to announce that the company was informed on September 20, 2013 by the R&D-based...

ELC GROUP, one of the fastest-growing providers of regulatory affairs consulting services, today announced that John Warren, a former Expert Medical Assessor for the UK Medicines Healthcare products Regulatory Agency (MHRA) has joined the ELC GROUP Advisory Board. ...

LATUDA® (lurasidone), a new once-daily treatment for schizophrenia, is now available in Switzerland for the treatment of schizophrenia.Research has shown that the atypical antipsychotic, lurasidone, has a specific receptor binding profile. Symptom control and reducing...

Veristat LLC. a leading Boston-based clinical research organization today announced its advisory role on the implementation of an adaptive enrichment trial design for Verastem Inc. . The enhanced design aims to optimize the current trial of defactinib a novel...

Oncodesign, a contract research laboratory dedicated to the discovery of new anticancer therapies, and Banook Central Imaging, a company specializing in the centralized reading of medical images, today announce the start of a partnership to expand the use of...